GoodRx Holdings, Inc. (GDRX) vs Replimune Group, Inc. (REPL)
A side-by-side comparison of GoodRx Holdings, Inc. and Replimune Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GDRX
GoodRx Holdings, Inc.
$3.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
REPL
Replimune Group, Inc.
$13.25HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — GDRX vs REPL
growth of $100 · dividends reinvested · last 6yGDRX -93.3% (-36.3%/yr)REPL -42.0% (-8.7%/yr)REPL compounded faster over this window
Log scale — wide-divergence pair
GDRX REPL
GDRX vs REPL: by the numbers
- •GDRX is the larger company ($1.13B vs $1.11B market cap).
- •GDRX is profitable (2.07% net margin) while REPL runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | GDRX | REPL |
|---|---|---|
| P/E ratio | 76.94 | N/A |
| P/S ratio | 1.44 | N/A |
| P/B ratio | 1.75 | 10.54 |
| EV / EBITDA | 8.14 | N/A |
| FCF yield | 12.86% | N/A |
Profitability
| Metric | GDRX | REPL |
|---|---|---|
| Gross margin | 88.05% | 0.00% |
| Operating margin | 10.25% | 0.00% |
| Net margin | 2.07% | 0.00% |
| ROE | 2.51% | -281.14% |
| ROIC | 3.72% | -139.11% |
Growth (annualized)
| Metric | GDRX | REPL |
|---|---|---|
| Revenue CAGR (5Y) | 4.47% | N/A |
| FCF CAGR (5Y) | 11.72% | N/A |
| Total return CAGR (5Y) | -39.98% | -15.17% |
Frequently asked
- Is GDRX or REPL more profitable?
- GDRX runs the higher net margin — GDRX at 2.07% versus REPL at 0.00%.
- How have GDRX and REPL total returns compared?
- Over the past 5 years, GDRX delivered -39.98% and REPL delivered -15.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
GoodRx P/E ratioGoodRx ROEReplimune ROEGoodRx operating marginReplimune operating marginGoodRx revenue growthReplimune revenue growthGoodRx free cash flowReplimune free cash flow
GoodRx & Replimune appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.